MENU
+Compare
VNRX
Stock ticker: ASE
AS OF
Dec 3, 04:59 PM (EDT)
Price
$0.28
Change
-$0.02 (-6.67%)
Capitalization
35.8M

VNRX VolitionRX Limited Forecast, Technical & Fundamental Analysis

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19... Show more

VNRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for VNRX with price predictions
Nov 28, 2025

VNRX's RSI Indicator climbs out of oversold territory

The RSI Oscillator for VNRX moved out of oversold territory on November 26, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In of the 25 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for VNRX just turned positive on November 26, 2025. Looking at past instances where VNRX's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VNRX advanced for three days, in of 229 cases, the price rose further within the following month. The odds of a continued upward trend are .

VNRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VNRX as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VNRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VNRX entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (63.271). P/E Ratio (0.000) is within average values for comparable stocks, (37.178). VNRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.671). VNRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (19.802) is also within normal values, averaging (35.282).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VNRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VNRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
VNRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

VNRX is expected to report earnings to fall 3.40% to -4 cents per share on March 31

VolitionRX Limited VNRX Stock Earnings Reports
Q4'25
Est.
$-0.05
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.01
Q1'25
Missed
by $0.02
Q4'24
Est.
$-0.05
The last earnings report on November 13 showed earnings per share of -5 cents, missing the estimate of -3 cents. With 646.12K shares outstanding, the current market capitalization sits at 35.80M.
A.I. Advisor
published General Information

General Information

a development stage life sciences company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
1489 West Warm Springs Road
Phone
+1 646 650-1351
Employees
110
Web
https://www.volition.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APH141.482.26
+1.62%
Amphenol Corp
DFIN48.360.38
+0.79%
Donnelley Financial Solutions
NL5.47-0.01
-0.27%
NL Industries
PTCT78.50-0.71
-0.89%
PTC Therapeutics
STRR10.10-0.15
-1.48%
Star Equity Holdings Inc

VNRX and Stocks

Correlation & Price change

A.I.dvisor tells us that VNRX and STRRP have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VNRX and STRRP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNRX
1D Price
Change %
VNRX100%
+2.06%
STRRP - VNRX
27%
Poorly correlated
+0.15%
SRDX - VNRX
25%
Poorly correlated
N/A
VAPO - VNRX
25%
Poorly correlated
N/A
IMDX - VNRX
24%
Poorly correlated
-5.56%
RMD - VNRX
23%
Poorly correlated
+1.01%
More

Groups containing VNRX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNRX
1D Price
Change %
VNRX100%
+2.06%
Medical/Nursing Services
industry (214 stocks)
4%
Poorly correlated
+1.25%
Health Services
industry (421 stocks)
1%
Poorly correlated
+0.70%